Dogs can develop a condition strikingly similar to ulcerative colitis in humans, though it goes by different names in veterinary medicine. The most well-known form is called histiocytic ulcerative colitis (sometimes called granulomatous colitis), and it primarily affects the lining of the large intestine. While it shares some features with the human disease, canine ulcerative colitis has distinct causes, affects certain breeds far more than others, and responds to different treatments.
How Canine Colitis Differs From Human UC
In humans, ulcerative colitis is a chronic autoimmune condition driven largely by one branch of the immune system. In dogs, inflammatory bowel disease takes several forms: lymphocytic-plasmacytic colitis, eosinophilic colitis, histiocytic ulcerative colitis, and regional granulomatous colitis. Each involves different types of immune cells infiltrating the colon wall.
Histiocytic ulcerative colitis is the form most comparable to human UC. It causes ulceration and inflammation in the superficial layers of the colon, similar to the human disease. But the underlying mechanism is different. In dogs, bacteria appear to play a central role. A specific type of E. coli, called adherent-invasive E. coli, colonizes the colon wall and gets trapped inside immune cells called macrophages. These bacteria-laden macrophages accumulate in the tissue, driving chronic inflammation. The immune response in dogs also involves a mixed activation pattern rather than the more predictable immune pathway seen in human UC, which leads to different patterns of inflammation and different responses to treatment.
Breeds Most at Risk
Histiocytic ulcerative colitis has a strong breed predisposition. Boxers and French Bulldogs are by far the most commonly affected, typically developing symptoms as young dogs. The condition has also been reported in Mastiffs, Alaskan Malamutes, English Bulldogs, and Dobermans. The breed concentration strongly suggests a genetic component, likely involving differences in how the intestinal immune system handles bacteria. Researchers have compared this to genetic variants in humans that impair the gut’s ability to mount a proper immune response to invasive bacteria.
Symptoms to Watch For
The hallmark signs are those of large-bowel diarrhea: soft or loose stool, visible blood in the stool, straining to defecate, and noticeably more frequent bowel movements. Dogs may also lose weight, show decreased appetite, or appear lethargic as the condition progresses. These symptoms can look similar to other causes of colitis in dogs, including dietary intolerance, parasites, or stress-related diarrhea, so the pattern matters. If your dog has persistent bloody diarrhea that doesn’t resolve within a few days, or keeps coming back, that warrants veterinary attention, especially in a predisposed breed.
How Vets Diagnose It
Diagnosis requires colonoscopy with biopsy. Your vet will take small tissue samples from the colon lining and send them to a pathologist. The defining finding is the presence of PAS-positive macrophages, immune cells that stain a specific way because they contain trapped bacteria. This distinguishes histiocytic ulcerative colitis from other types of canine IBD.
Ultrasound can also provide useful clues before biopsy. In affected dogs, the descending colon wall appears markedly thickened, sometimes reaching around 10 mm, with loss of the normal layered appearance. The mucosa looks irregular, and color Doppler often reveals increased blood flow to the inflamed area. The ascending and transverse portions of the colon typically look normal, which helps narrow the diagnosis. However, ultrasound alone isn’t definitive. Biopsy remains the gold standard.
Treatment and Recovery Timeline
Because bacteria drive this condition, antibiotics are the primary treatment, which is a major departure from human UC management. Fluoroquinolone antibiotics, sometimes used alone and sometimes combined with other antibiotics, form the backbone of therapy. In one study of nine dogs, clinical signs resolved within 2 to 12 days of starting antibiotics. Dogs that had previously failed conventional anti-inflammatory treatments responded once antibiotics were added.
A larger study found that all treated dogs showed clinical improvement within two weeks. Treatment courses typically lasted around 9 to 10 weeks. Six out of seven dogs in that study achieved sustained remission, with a median disease-free interval of 47 months (nearly four years). Follow-up biopsies confirmed that the invasive E. coli had been cleared from the colon wall in most dogs that responded. The one dog that relapsed harbored antibiotic-resistant bacteria, highlighting why completing the full course of treatment matters.
Antibiotic resistance is a real concern. Some dogs with granulomatous colitis carry E. coli strains that don’t respond to standard fluoroquinolone therapy, which can complicate treatment. Your vet may culture the bacteria from biopsy samples to determine which antibiotics will be effective.
The Role of Diet
Diet alone won’t resolve histiocytic ulcerative colitis, but nutritional management plays a supporting role alongside medical treatment. Hydrolyzed protein diets, where the protein molecules are broken down small enough that they’re less likely to trigger immune reactions, are commonly recommended. These diets have been shown to promote the growth of beneficial gut bacteria, including Lactobacillus and Bifidobacterium species, in dogs with inflammatory bowel disease.
Novel protein diets, which use a protein source your dog hasn’t been exposed to before (like cod or venison), can also help reduce intestinal inflammation. Some dogs benefit from hydrolyzed protein diets combined with probiotic supplements, a combination associated with increased bacterial diversity in the gut and improved clinical signs. Your vet can help identify the best dietary approach based on your dog’s history and response to treatment.
When Standard Treatment Doesn’t Work
For dogs with chronic intestinal inflammation that doesn’t respond well to antibiotics and dietary changes, fecal microbiota transplant (FMT) is an emerging option. This involves transplanting processed stool from a healthy donor dog into the affected dog’s colon, essentially resetting the gut bacterial community.
A retrospective study of 41 dogs with poorly responsive chronic enteropathy found that 76% showed clinical improvement after FMT, with 26 of 41 dogs having a good sustained response. Dogs received a median of three transplants. Disease activity scores dropped significantly, and many dogs showed better stool quality and energy levels. Twelve dogs were able to reduce or stop other medications after FMT. Ten dogs that had been dependent on corticosteroids were able to taper to lower doses than had previously been possible. FMT is still considered an adjunctive therapy rather than a first-line treatment, but it offers a meaningful option for dogs that haven’t responded to conventional approaches.